Roche in India
Roche Products (India) Private Limited (formerly known as “Roche Scientific Company (India) Pvt. Ltd.”) was incorporated in 1994 as a wholly owned subsidiary of Roche Group. In November 2010, the company’s name was changed to "Roche Products (India) Pvt. Ltd."
Currently, Roche has products in therapeutic areas such as Oncology, Nephrology, Transplantation, Anemia and Rheumatoid Arthritis.
Roche Pharmaceuticals, India, has been disseminating scientific knowledge pertaining to innovative medicines to the medical fraternity. From January 1, 2013, Roche Products (India) Private Limited commenced wholesale trading, thereby entering the business of direct buying and selling in India.
Roche has always endeavored to launch new molecules in the Indian market in a timely manner.
In Oncology, Roche has developed and introduced a number of targeted novel medicines to treat different forms of cancer, thus providing new treatment options and improving the life span of cancer patients worldwide. With major advances in early diagnosis and better-targeted drugs, Roche India is at the forefront of oncology research. These drugs have advanced mechanisms of action, which provides accelerated progress in fighting cancer.
In recognition of its contributions in Oncology, Roche India has been awarded the ‘Best Oncology Company of the Year,’ by Frost & Sullivan at the India Healthcare Excellence Awards for the years 2011, 2012 and 2014.
In the therapeutic area of transplantation, Roche has developed innovative therapies that improve graft and post-transplant health thus enhancing the quality of life of the transplant recipients.
At Roche, our focus is to benefit patients in need. Over the past years, innovative approaches pioneered at Roche have led to breakthrough drug therapies for common and serious diseases.